{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:37:45Z","timestamp":1789677465509,"version":"4.0.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["N42A670287"],"award-info":[{"award-number":["N42A670287"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023924","name":"Chulalongkorn University Graduate School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.biopha.2024.117783","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T02:48:17Z","timestamp":1735181297000},"page":"117783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ligand docking in the sigma-1 receptor compared to the sigma-1 receptor-BiP complex and the effects of agonists and antagonists on C. elegans lifespans"],"prefix":"10.1016","volume":"182","author":[{"given":"Kanika","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani Iyer","family":"Prasanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewin","family":"Tencomnao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-8262","authenticated-orcid":false,"given":"James Michael","family":"Brimson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117783_bib1","article-title":"Using model animals to assess and understand developmental toxicity","author":"Council","year":"2000","journal-title":"Sci. Front. Dev. Toxicol. Risk Assess."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.celrep.2018.12.051","article-title":"Choline is an intracellular messenger linking extracellular stimuli to IP3-Evoked Ca2+\u2009signals through sigma-1 receptors","volume":"26","author":"Brailoiu","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037989","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors","volume":"7","author":"Ishima","year":"2012","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.biopha.2024.117783_bib4","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.pnpbp.2008.06.011","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors","volume":"32","author":"Ishima","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12858-015-0040-y","article-title":"Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria","volume":"16","author":"Natsvlishvili","year":"2015","journal-title":"BMC Biochem."},{"issue":"2 B","key":"10.1016\/j.biopha.2024.117783_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1476-5381.2011.01417.x","article-title":"Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptor","volume":"164","author":"Brimson","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"52","key":"10.1016\/j.biopha.2024.117783_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.0909089106","article-title":"Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1\u2022GTP pathway","volume":"106","author":"Tsai","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2024.117783_bib8","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1167\/iovs.08-1867","article-title":"Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction","volume":"49","author":"Tchedre","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1124\/jpet.106.107557","article-title":"Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia","volume":"319","author":"Katnik","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib10","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1046\/j.1471-4159.1997.68052201.x","article-title":"Protein phosphorylation and calcium uptake into rat forebrain synaptosomes: modulation by the sigma ligand, 1,3-ditolylguanidine","volume":"68","author":"Brent","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2024.117783_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.02.070","article-title":"Sigma-1 receptor alters the kinetics of Kv1. 3 voltage gated potassium channels but not the sensitivity to receptor ligands","volume":"1452","author":"Kinoshita","year":"2012","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.107.122044","article-title":"\u03c32-receptor ligand-mediated inhibition of inwardly rectifying K+\u2009channels in the heart","volume":"322","author":"Monassier","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib13","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1007\/s12035-023-03717-w","article-title":"Sigma-1 receptor inhibition reduces mechanical allodynia and modulate neuroinflammation in chronic neuropathic pain","volume":"61","author":"Denaro","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/ejp.4755","article-title":"E-52862\u2014A selective sigma-1 receptor antagonist, in peripheral neuropathic pain: two randomized, double-blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy","volume":"29","author":"G\u00e1lvez","year":"2025","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.biopha.2024.117783_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jconrel.2024.09.040","article-title":"PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer","volume":"375","author":"Huangfu","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40263-023-01007-6","article-title":"Targeting sigma receptors for the treatment of neurodegenerative and neurodevelopmental disorders","volume":"37","author":"Malar","year":"2023","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41398-024-03185-3","article-title":"Sertraline modulates hippocampal plasticity via sigma 1 receptors, cellular stress and neurosteroids","volume":"14","author":"Izumi","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2024.117783_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X241281547","article-title":"Sigma-1 receptor signaling: a potential therapeutic approach for ischemic stroke","author":"Ngo","year":"2024","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-65849-6","article-title":"Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression","volume":"10","author":"Brimson","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2024.117783_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41401-023-01201-8","article-title":"Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels","volume":"45","author":"Ma","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.biopha.2024.117783_bib21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/14728222.2020.1805435","article-title":"Using Sigma-ligands as part of a multi-receptor approach to target diseases of the brain","volume":"24","author":"Brimson","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.biopha.2024.117783_bib22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jalz.2017.11.009","article-title":"AF710B, an M1\/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease","volume":"14","author":"Hall","year":"2018","journal-title":"Alzheimer'S. Dement."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-017-0380-6","article-title":"Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases","volume":"24","author":"Weng","year":"2017","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13311-018-00699-9","article-title":"Pridopidine induces functional neurorestoration via the sigma-1 receptor in a mouse model of Parkinson\u2019s disease","volume":"16","author":"Francardo","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2024.117783_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nbd.2014.11.005","article-title":"Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease","volume":"74","author":"Miki","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2024.117783_bib26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(11)70233-2","article-title":"Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"De Yebenes","year":"2011","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117783_bib27","first-page":"435","article-title":"The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer\u2019s disease","volume":"25","author":"Prasanth","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2024.117783_bib28","doi-asserted-by":"crossref","first-page":"8836818","DOI":"10.1155\/2021\/8836818","article-title":"Stimulation of sigma-1 receptor protects against cardiac fibrosis by alleviating IRE1 pathway and autophagy impairment","volume":"2021","author":"Qu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030211","article-title":"Sigma-1 receptor activation induces autophagy and increases proteostasis capacity in vitro and in vivo","volume":"8","author":"Christ","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.117783_bib30","article-title":"Sigma-1 receptor ablation impairs autophagosome clearance","volume":"14","author":"Yang","year":"2019","journal-title":"Autophagy"},{"issue":"53","key":"10.1016\/j.biopha.2024.117783_bib31","doi-asserted-by":"crossref","first-page":"91099","DOI":"10.18632\/oncotarget.19556","article-title":"Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma","volume":"8","author":"Longhitano","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.biopha.2024.117783_bib32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/14728222.2022.2166829","article-title":"Repurposing fluoxetine to treat lymphocytic leukemia: apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction","volume":"26","author":"Chomchoei","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"issue":"8","key":"10.1016\/j.biopha.2024.117783_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114619","article-title":"Sigma-1 receptor recruits LC3 mRNA to ER-associated omegasomes to promote localized LC3 translation enabling functional autophagy","volume":"43","author":"Knupp","year":"2024","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib34","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3390\/ijms24031997","article-title":"Sigma-1 receptor signaling: in search of new therapeutic alternatives for cardiovascular and renal diseases","volume":"24","author":"Munguia-Galaviz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117783_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111382","article-title":"Activation of sigma-1 receptor ameliorates sepsis-induced myocardial injury by mediating the Nrf2\/HO1 signaling pathway to attenuate mitochondrial oxidative stress","volume":"127","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117783_bib36","doi-asserted-by":"crossref","first-page":"1255971","DOI":"10.3389\/fmicb.2023.1255971","article-title":"Sigma-1 receptor knockout disturbs gut microbiota, remodels serum metabolome, and exacerbates isoprenaline-induced heart failure","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib37","first-page":"401","article-title":"Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: the possible role of the Sigma-1 receptor and autophagy","volume":"25","author":"Brimson","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2024.117783_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117783_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20141321","article-title":"The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands","volume":"466","author":"Mishra","year":"2015","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.119.262790","article-title":"Distinct regulation of \u03c31 receptor multimerization by its agonists and antagonists in transfected cells and rat liver membranes","volume":"373","author":"Hong","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"29","key":"10.1016\/j.biopha.2024.117783_bib41","doi-asserted-by":"crossref","first-page":"20333","DOI":"10.1074\/jbc.M113.537993","article-title":"The oligomeric states of the purified sigma-1 receptor are stabilized by ligands","volume":"289","author":"Gromek","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.biopha.2024.117783_bib42","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1021\/acs.jcim.4c00500","article-title":"Exploring structural requirements for sigma-1 receptor linear ligands: experimental and computational approaches","volume":"64","author":"Lombardo","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"10.1016\/j.biopha.2024.117783_bib43","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","article-title":"The trRosetta server for fast and accurate protein structure prediction","volume":"16","author":"Du","year":"2021","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.biopha.2024.117783_bib44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2024.117783_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinforma."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"issue":"15","key":"10.1016\/j.biopha.2024.117783_bib47","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the swiss-Pdb viewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"electrophoresis"},{"issue":"D1","key":"10.1016\/j.biopha.2024.117783_bib48","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.117783_bib49","first-page":"845","article-title":"The performance of current methods in ligand\u2013protein docking","author":"McConkey","year":"2002","journal-title":"Curr. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib50","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1038\/s41598-021-84700-0","article-title":"Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants","volume":"11","author":"Guedes","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117783_bib51","author":"Jejurikar","year":"2021","journal-title":"Drug Des. Discov. Stud."},{"issue":"W1","key":"10.1016\/j.biopha.2024.117783_bib52","doi-asserted-by":"crossref","first-page":"W322","DOI":"10.1093\/nar\/gkz397","article-title":"HawkDock: a web server to predict and analyze the protein\u2013protein complex based on computational docking and MM\/GBSA","volume":"47","author":"Weng","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib54","first-page":"71","article-title":"Caenorhabdztzs elegans","volume":"77","author":"Brenner","year":"1974","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2024.117783_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116455","article-title":"Simple ammonium salt and sigma-1 receptor ligand dipentylammonium provides neuroprotective effects in cell culture and Caenorhabditis elegans models of Alzheimer's disease","volume":"173","author":"Prasanth","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/NHA-200108","article-title":"Cleistocalyx nervosum var. paniala seed extracts exhibit sigma-1 antagonist sensitive neuroprotective effects in PC12 cells and protects C. elegans from stress via the SKN-1\/NRF-2 pathway","volume":"6","author":"Brimson","year":"2021","journal-title":"Nutr. Healthy Aging"},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jtcme.2019.10.001","article-title":"Bacopa monnieri (L.) wettst. Extract protects against glutamate toxicity and increases the longevity of Caenorhabditis elegans","volume":"10","author":"Brimson","year":"2020","journal-title":"J. Tradit. Complement. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib58","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1038\/s41467-024-49894-7","article-title":"Insight into binding of endogenous neurosteroid ligands to the sigma-1 receptor","volume":"15","author":"Fu","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2024.117783_bib59","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jmb.2015.02.011","article-title":"BiP and its nucleotide exchange factors Grp170 and Sil1: mechanisms of action and biological functions","volume":"427","author":"Behnke","year":"2015","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12035-020-02124-9","article-title":"Haloperidol interactions with the dop-3 receptor in caenorhabditis elegans","volume":"58","author":"Krum","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.117783_bib61","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2018.01.009","article-title":"The sigma-1 receptor as a regulator of dopamine neurotransmission: a potential therapeutic target for methamphetamine addiction","volume":"186","author":"Sambo","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"43","key":"10.1016\/j.biopha.2024.117783_bib62","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.1008911107","article-title":"Direct involvement of \u03c3-1 receptors in the dopamine D1 receptor-mediated effects of cocaine","volume":"107","author":"Navarro","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-3565(25)20949-1","article-title":"Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors","volume":"279","author":"Lynch","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/acel.12163","article-title":"A pharmacological network for lifespan extension in aenorhabditis elegans","volume":"13","author":"Ye","year":"2014","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12868-024-00902-y","article-title":"ZA-II-05, a novel NMDA-receptor antagonist reverses vanadium-induced neurotoxicity in Caenorhabditis elegans (C. elegans)","volume":"25","author":"Ladagu","year":"2024","journal-title":"BMC Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2024.117783_bib66","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/acel.12379","article-title":"Atypical antidepressants extend lifespan of Caenorhabditis elegans by activation of a non-cell-autonomous stress response","volume":"14","author":"Rangaraju","year":"2015","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib67","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1097-2765(00)80362-7","article-title":"Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins","volume":"4","author":"Choy","year":"1999","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glad220","article-title":"Fluoxetine promotes longevity via reactive oxygen species in caenorhabditis elegans","volume":"79","author":"Zhou","year":"2024","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00018-023-05023-z","article-title":"Benzomorphan and non-benzomorphan agonists differentially alter sigma-1 receptor quaternary structure, as does types of cellular stress","volume":"81","author":"Couly","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib70","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/acs.jcim.9b00649","article-title":"New insights into the opening of the occluded ligand-binding pocket of sigma1 receptor: binding of a novel bivalent RC-33 derivative","volume":"60","author":"Rossino","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"16","key":"10.1016\/j.biopha.2024.117783_bib71","doi-asserted-by":"crossref","first-page":"12980","DOI":"10.3390\/ijms241612980","article-title":"Structure-based modeling of sigma 1 receptor interactions with ligands and cholesterol and implications for its biological function","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117783_bib72","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65192","article-title":"The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains","volume":"10","author":"Zhemkov","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2024.117783_bib73","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-017-0524-y","article-title":"Haloperidol affects plasticity of differentiated NG-108 cells through \u03c31R\/IP 3 R1 complex","volume":"38","author":"Kubickova","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117783_bib74","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/cbdd.13841","article-title":"Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix\u2013helix interactions","volume":"97","author":"Xu","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"issue":"11","key":"10.1016\/j.biopha.2024.117783_bib75","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/biom11111681","article-title":"The \u03c31 Receptor and the HINT1 protein control \u03b12\u03b41 binding to glutamate NMDA receptors: implications in neuropathic pain","volume":"11","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2021","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.biopha.2024.117783_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108006","article-title":"Structural determinants of M2R involved in inhibition by Sigma-1R","volume":"300","author":"Liu","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12640-018-9883-5","article-title":"Dipentylammonium binds to the sigma-1 receptor and protects against glutamate toxicity, attenuates dopamine toxicity and potentiates neurite outgrowth in various cultured cell lines","volume":"34","author":"Brimson","year":"2018","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib78","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/syn.20230","article-title":"Differences in the allosteric modulation by phenytoin of the binding properties of the \u03c31 ligands [3H](+)-pentazocine and [3H]NE-100","volume":"59","author":"Cobos","year":"2006","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib79","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib80","first-page":"626","article-title":"Effect of BD 1047, a sigma1 receptor antagonist, in the animal models predictive of antipsychotic activity","volume":"58","author":"Skuza","year":"2006","journal-title":"Pharm. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2024.117783_bib81","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/ALN.0b013e3181895a83","article-title":"Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain","volume":"109","author":"Roh","year":"2008","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","article-title":"Characterization of two novel \u03c3 receptor ligands: antidystonic effects in rats suggest \u03c3 receptor antagonism","volume":"280","author":"Matsumoto","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117783_bib83","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.phrs.2016.05.031","article-title":"Are fluoxetine\u2019s effects due to sigma-1 receptor agonism?","volume":"113","author":"Safrany","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab050","article-title":"Prospective cohort of fluvoxamine for early treatment of Coronavirus disease 19","volume":"8","author":"Seftel","year":"2021","journal-title":"Open Forum Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib85","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-020-05753-z","article-title":"Fluvoxamine, melatonin and COVID-19","volume":"238","author":"Anderson","year":"2021","journal-title":"Psychopharmacology"},{"issue":"22","key":"10.1016\/j.biopha.2024.117783_bib86","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.biopha.2024.117783_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0209250","article-title":"Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors","volume":"13","author":"Terada","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2024.117783_bib88","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/JCP.0000000000000850","article-title":"Evaluation of the effect of fluvoxamine in patients with schizophrenia under risperidone treatment: a clinical trial","volume":"38","author":"Javadi","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2024.117783_bib89","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/WNR.0000000000000162","article-title":"Antidepressant fluvoxamine reduces cerebral infarct volume and ameliorates sensorimotor dysfunction in experimental stroke","volume":"25","author":"Sato","year":"2014","journal-title":"Neuroreport"},{"issue":"1-3","key":"10.1016\/j.biopha.2024.117783_bib90","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2012.09.030","article-title":"Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine","volume":"696","author":"Sugimoto","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib91","article-title":"Fluvoxamine alone in the treatment of delusional depression","volume":"153","author":"Gatti","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2024.117783_bib92","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1471-4159.2007.04533.x","article-title":"Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells","volume":"102","author":"Cobos","year":"2007","journal-title":"J. Neurochem."},{"issue":"536","key":"10.1016\/j.biopha.2024.117783_bib93","article-title":"N, N-dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine its role and function","volume":"12","author":"Barker","year":"2018","journal-title":"Front. Neurosci."},{"issue":"5916","key":"10.1016\/j.biopha.2024.117783_bib94","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.biopha.2024.117783_bib95","doi-asserted-by":"crossref","first-page":"PL285","DOI":"10.1016\/0024-3205(93)90588-T","article-title":"NE-100, a novel sigma receptor ligand: In vivo tests","volume":"53","author":"Okuyama","year":"1993","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.117783_bib96","article-title":"Comparison of sigma 1 receptor (Sig1R) ligands SA4503, PRE084 and (+)-pentazocine ((+)-PTZ) for their cone photoreceptor (PRC) rescue effects in the Pde6brd10\/J (rd10) mouse model of retinitis pigmentosa","volume":"61","author":"Xiao","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117783_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2004.tb00001.x","article-title":"Review of the pharmacological and clinical profile of rimcazole","volume":"10","author":"Gilmore","year":"2004","journal-title":"CNS Drug Rev."},{"issue":"14","key":"10.1016\/j.biopha.2024.117783_bib98","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-03-3180","article-title":"Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo","volume":"64","author":"Spruce","year":"2004","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.117783_bib99","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1007\/s12035-017-0697-x","article-title":"The sigma-1 receptor antagonist, S1RA, reduces stroke damage, ameliorates post-stroke neurological deficits and suppresses the overexpression of MMP-9","volume":"55","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1-3","key":"10.1016\/j.biopha.2024.117783_bib100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(96)00201-4","article-title":"Binding properties of SA4503, a novel and selective sigma 1 receptor agonist","volume":"306","author":"Matsuno","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117783_bib101","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1161\/STROKEAHA.114.005835","article-title":"Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke","volume":"45","author":"Urfer","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.biopha.2024.117783_bib102","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2174\/138161212799436476","article-title":"Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases","volume":"18","author":"Niitsu","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2024.117783_bib103","series-title":"Sigma Receptors: Their Role in Disease and as Therapeutic Targets","first-page":"153","article-title":"Sigma-1 receptor agonists and their clinical implications in neuropsychiatric disorders","author":"Albayrak","year":"2017"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224016706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:12:28Z","timestamp":1776726748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224016706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":103,"alternative-id":["S0753332224016706"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117783","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand docking in the sigma-1 receptor compared to the sigma-1 receptor-BiP complex and the effects of agonists and antagonists on C. elegans lifespans","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117783"}}